Researchers Take A Closer Look At Extended Revlimid-Dexamethasone ... The Myeloma Beacon Among a large sample of patients who were initially treated with Revlimid and dexamethasone after diagnosis – and who did not undergo an early stem cell transplant – one fifth received the two-drug therapy for more than three years. Almost two ... |
